Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.5700
0.00 (0.00%)
Feb 9, 2026, 11:15 AM AEST
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 13.09 million as of February 10, 2026. Its market cap has increased by 213.51% in one year.
Market Cap
13.09M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.57
Market Cap Chart
Since April 5, 2024, Cambium Bio's market cap has increased from 7.97M to 13.09M, an increase of 64.32%. That is a compound annual growth rate of 30.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 13.09M | 21.28% |
| Dec 31, 2025 | 10.80M | 103.21% |
| Dec 31, 2024 | 5.31M | -33.33% |
| Apr 5, 2024 | 7.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurotech International | 18.80M |
| Patrys | 18.19M |
| Noxopharm | 17.24M |
| AdAlta | 11.47M |
| Tissue Repair | 11.19M |
| Chimeric Therapeutics | 11.05M |
| Bio-Gene Technology | 10.07M |
| Immuron | 9.77M |